Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening cardiomyopathies, today announced that the first ...

Type 1 diabetes requires lifelong insulin therapy, while some people with Type 2 diabetes can achieve drug-free remission ...

FDA grants Fast Track designation to NVC-001 as the SUNBEAM-LMNA trial evaluates the safety and potential of a one-time gene therapy for aggressive inherited heart disease with no approved ...

When calculating the output size of a CNN, thinking about "how many times the filter can be placed" before plugging numbers ...

NASCAR Hall of Fame driver Fred Lorenzen has been diagnosed posthumously with Chronic Traumatic Encephalopathy, a brain disease otherwise known as CTE. His diagnosis is the first known case of CTE in ...

A meta-analysis of 72 randomized controlled trials shows aerobic exercise improves endothelial function by 2.35 percent, an ...

Brytly is the first nonprescription eye drop that contains apraclonidine, and the Food and Drug Administration approved it on ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Health Canada has issued a Notice of Compliance authorizing MYQORZO® (aficamten) for the treatment of symptomatic obstructive ...

Affinia Therapeutics ("Affinia"), an innovative clinical-stage gene therapy company with a pipeline of first-in-class and/or ...

Those who eat it suffer so much in their frenzy that they run around in circles=͟͟͞͞ / ˙꒳​˙)/Every year, from early spring to ...

A qualitative study of ten ethnic minority women in Leicester exposes how severe childbirth tears leave lasting physical and ...

Viking Therapeutics rode strong obesity data before a major capital raise, while Longeveron’s mid-stage setback prompted questions about its future.